1. Home
  2. FATE vs NEON Comparison

FATE vs NEON Comparison

Compare FATE & NEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • NEON
  • Stock Information
  • Founded
  • FATE 2007
  • NEON 1997
  • Country
  • FATE United States
  • NEON Sweden
  • Employees
  • FATE N/A
  • NEON N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • NEON Industrial Machinery/Components
  • Sector
  • FATE Health Care
  • NEON Technology
  • Exchange
  • FATE Nasdaq
  • NEON Nasdaq
  • Market Cap
  • FATE 142.4M
  • NEON 161.3M
  • IPO Year
  • FATE 2013
  • NEON 2007
  • Fundamental
  • Price
  • FATE $1.42
  • NEON $9.61
  • Analyst Decision
  • FATE Hold
  • NEON Strong Buy
  • Analyst Count
  • FATE 10
  • NEON 1
  • Target Price
  • FATE $6.75
  • NEON $16.50
  • AVG Volume (30 Days)
  • FATE 2.1M
  • NEON 93.6K
  • Earning Date
  • FATE 03-04-2025
  • NEON 03-19-2025
  • Dividend Yield
  • FATE N/A
  • NEON N/A
  • EPS Growth
  • FATE N/A
  • NEON N/A
  • EPS
  • FATE N/A
  • NEON N/A
  • Revenue
  • FATE $13,447,000.00
  • NEON $3,795,000.00
  • Revenue This Year
  • FATE N/A
  • NEON $5.89
  • Revenue Next Year
  • FATE N/A
  • NEON $2.61
  • P/E Ratio
  • FATE N/A
  • NEON N/A
  • Revenue Growth
  • FATE N/A
  • NEON N/A
  • 52 Week Low
  • FATE $1.04
  • NEON $1.23
  • 52 Week High
  • FATE $8.83
  • NEON $15.00
  • Technical
  • Relative Strength Index (RSI)
  • FATE 48.76
  • NEON 58.88
  • Support Level
  • FATE $1.43
  • NEON $9.26
  • Resistance Level
  • FATE $1.81
  • NEON $10.25
  • Average True Range (ATR)
  • FATE 0.14
  • NEON 0.57
  • MACD
  • FATE 0.05
  • NEON 0.02
  • Stochastic Oscillator
  • FATE 39.06
  • NEON 70.64

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in United States, Japan, South Korea, Germany, Switzerland, China, France, Sweden and Others. It derives maximum revenue from United States.

Share on Social Networks: